BriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT)
BriaCell Therapeutics is among the group of undervalued stocks on the Toronto Stock Exchange. This means the consensus value for each stock on this list is above its current price.
This report is generated monthly. It provides the close price and target price for these companies along with the number of analysts covering the stock. Also included is the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year. Stocks in this category are held primarily for capital appreciation. There may be a number of reasons why a company would be on this list. Companies with a large analyst following with a difference in price versus target are worth exploring in more detail.
| Symbol | Name | Close Price | Target Year | Target Price Mean | Currency | Target Price Number of Estimates |
|---|---|---|---|---|---|---|
| CJT-T | Cargojet Inc | 93.96 | 2,023 | 149.5 | CAD | 12 |
| DOO-T | BRP Inc | 110.16 | 2,023 | 145.364 | CAD | 11 |
| GRT-UN-T | Granite Real Estate Investment Trust | 77.35 | 2,023 | 100.05 | CAD | 12 |
| L-T | Loblaw Companies Ltd | 119.34 | 2,023 | 140.812 | CAD | 8 |
| LAS-A-T | Lassonde Industries Inc | 108.5 | 2,023 | 130 | CAD | 1 |
| AIF-T | Altus Group Ltd | 43.5 | 2,023 | 62.375 | CAD | 8 |
| CNR-T | Canadian National Railway Co | 155.01 | 2,023 | 176.562 | CAD | 13 |
| MEQ-T | Mainstreet Equity Corp | 133.21 | 2,024 | 163.333 | CAD | 3 |
| PD-T | Precision Drilling Corp | 74.53 | 2,023 | 110.8 | CAD | 10 |
| BYD-T | Boyd Group Services Inc | 244.18 | 2,023 | 272.4 | CAD | 10 |
| DRM-T | DREAM Unlimited Corp | 20.23 | 2,023 | 40 | CAD | 2 |
| CGO-T | Cogeco Inc | 52 | 2,024 | 84.5 | CAD | 2 |
| FFH-U-T | Fairfax Financial Holdings Ltd | 734.31 | 2,023 | 1,284.533 | CAD | 6 |
| AFN-T | Ag Growth International Inc | 52.16 | 2,023 | 71.8 | CAD | 10 |
| MRC-T | Morguard Corp | 102.02 | 2,023 | 140 | CAD | 1 |
| IFC-T | Intact Financial Corp | 197.37 | 2,023 | 220.083 | CAD | 12 |
| CGY-T | Calian Group Ltd | 63.85 | 2,024 | 80.857 | CAD | 7 |
| APS-T | Aptose Biosciences Inc | 5.75 | 2,023 | 36.369 | CAD | 2 |
| TCS-T | Tecsys Inc | 26.51 | 2,024 | 46.8 | CAD | 5 |
| WFG-T | West Fraser Timber Co.Ltd | 114.2 | 2,023 | 136.828 | CAD | 7 |
| WN-T | George Weston Ltd | 154.36 | 2,023 | 195.857 | CAD | 7 |
| TIH-T | Toromont Industries Ltd | 108.56 | 2,023 | 124.75 | CAD | 8 |
| GSY-T | goeasy Ltd | 123.26 | 2,023 | 162.1 | CAD | 10 |
| TSU-T | Trisura Group Ltd | 37.05 | 2,023 | 53.714 | CAD | 7 |
| BCT-T | BriaCell Therapeutics Corp | 8.48 | 2,024 | 25 | USD | 1 |
More about BriaCell Therapeutics Corp
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in advanced metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advanced-stage breast cancer by matching the patient's HLA type.
Artificial intelligence at Report on Business
AI at The Globe and Mail This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
